Synthetic Biology – News and Features

By reproducing in the laboratory the complex interactions that cause human genes to turn on inside cells, researchers have created a system they believe can benefit gene therapy research and the burgeoning field of synthetic biology.

Lophius Biosciences announces the closing of a further financing round with Prof. Dr Ralf Wagner been appointed as Managing Director.

Expansion of product portfolio in the field of T-cell based diagnostics.

University of Bristol scientists have been awarded a £1.1 million share of the Biotechnology and Biological Sciences Research Council (BBSRC)'s strategic Longer and Larger Awards in Synthetic Biology.

The science and ethics of synthetic biology and what it means for the UK will be the subject of a Royal Society of Chemistry debate to be streamed live on Wednesday 14 November.

New sensor can detect four different molecules, could be used to program cells to precisely monitor their environments.

New approach could greatly improve ability of researchers and physicians to control gene expression.

Chemical and biomolecular engineering professor Jay Keasling, the Hubbard Howe Jr. Distinguished Professor in Biochemical Engineering, has been named as award recipient.

Latest issue of IDT’s Decoded newsletter explains the fundamentals of artificial gene construction.

HMS professor leads effort to streamline biological engineering.